Discover 165 paid clinical trials in Savannah, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 165
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Savannah GA, Lawrenceville GA, Decatur GA, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
for
Alzheimer Disease, Dementia
Location: Savannah GA, Matthews NC, Lady Lake FL, Maitland FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 55 - 70+
Code: NCT06721156
Phase2, Recruiting
Active & Responsive
A Study of Barzolvolimab in Patients With Atopic Dermatitis
for
Atopic Dermatitis
Location: Savannah GA, Simpsonville SC, Atlanta GA, Columbus GA,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT06727552
Phase2, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Savannah GA, Bluffton SC, Hilton Head Island SC,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Savannah GA, Jacksonville FL, Saint Augustine FL,
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058039
Phase3, Recruiting
Active & Responsive
VK2735 for Weight Management Phase 3
for
Weight Loss
Location: Savannah GA, Rincon GA, North Charleston SC,
Sponsor: Viking Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07104500
Phase3, Recruiting
Active & Responsive
An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
for
Respiratory Syncytial Virus Infections
Location: Savannah GA, Mt. Pleasant SC, Jacksonville FL,